Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 4Prostatic Neoplasms 3Glioma 3Wilms Tumor 2Lung Neoplasms 2Glioblastoma 2Carcinoma, Intraductal, Noninfiltrating 2Brain Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Solitary Fibrous Tumor, Pleural 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pancreatic Intraductal Neoplasms 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neuroblastoma 1Neoplasms 1Metastatic Malignant Female Reproductive System Neoplasm 1Mesothelioma, Malignant 1Head and Neck Neoplasms 1Germinoma 1Ganglioneuroblastoma 1Extensive Stage Small Cell Lung Carcinoma 1Ependymoma 1Down Syndrome 1Diabetes Insipidus 1Central Nervous System Nongerminomatous Germ Cell Tumor 1Central Nervous System Neoplasms 1

Interventions

Cytarabine 6Vincristine 4Methotrexate 4Mercaptopurine 4pegaspargase 3merphos 3dexamethasone acetate 3dexamethasone 21-phosphate 3azathiopurine 3auricularum 3Thioguanine 3Dexamethasone 3Daunorubicin 3Cyclophosphamide 3Calcium Dobesilate 3Asparaginase 3prednylidene 2blinatumomab 2asparaginase erwinia chrysanthemi recombinant 2Prednisolone 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2Leucovorin 2Hydrocortisone 2Etoposide 2Doxorubicin 2hydrocortisone hemisuccinate 1deltacortene 1calaspargase pegol 1Spinal Puncture 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Down Syndrome × Radiotherapy, Conformal × 1 year × Clear all
NCT04546399 2025-09-10

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

National Cancer Institute (NCI)

Phase 2 Recruiting
461 enrolled
Lymphoid

Burkitt Lymphoma, Down Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡